| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Chief Financial Officer | $12.4M | -$7.87M | -38.9% | Aug 12, 2025 |
| SYRE | Spyre Therapeutics, Inc. | Director | Jun 22, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|